Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, July 17, 2024 | Back issues
Courthouse News Service Courthouse News Service

Unfair Competition

LOS ANGELES - Hospira, International Medication Systems and American Regent are marketing an unapproved epinephrine-injection product that improperly competes with the Food and Drug Administration-approved Adrenalin, JHP Pharmaceuticals claims in Federal Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...